These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31620045)

  • 1. Aberrant Salience Across Levels of Processing in Positive and Negative Schizotypy.
    Chun CA; Brugger P; Kwapil TR
    Front Psychol; 2019; 10():2073. PubMed ID: 31620045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent inhibition, aberrant salience, and schizotypy traits in cannabis users.
    Dawes C; Quinn D; Bickerdike A; O'Neill C; Granger KT; Pereira SC; Mah SL; Haselgrove M; Waddington JL; O'Tuathaigh C; Moran PM
    Schizophr Res Cogn; 2022 Jun; 28():100235. PubMed ID: 35028297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant salience predicts psychotic-like experiences in daily life: An experience sampling study.
    Chun C; Gross G; Mielock A; Kwapil T
    Schizophr Res; 2020 Jun; 220():218-224. PubMed ID: 32249121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the construct validity of aberrant salience.
    Schmidt K; Roiser JP
    Front Behav Neurosci; 2009; 3():58. PubMed ID: 20057930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does cannabis use predict psychometric schizotypy via aberrant salience?
    O'Tuathaigh CMP; Dawes C; Bickerdike A; Duggan E; O'Neill C; Waddington JL; Moran PM
    Schizophr Res; 2020 Jun; 220():194-200. PubMed ID: 32273148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant Salience Is Related to Dysfunctional Self-Referential Processing in Psychosis.
    Pankow A; Katthagen T; Diner S; Deserno L; Boehme R; Kathmann N; Gleich T; Gaebler M; Walter H; Heinz A; Schlagenhauf F
    Schizophr Bull; 2016 Jan; 42(1):67-76. PubMed ID: 26194892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis Use, Schizotypy and Kamin Blocking Performance.
    Dawes C; Bickerdike A; O'Neill C; Carneiro Pereira S; Waddington JL; Moran PM; O'Tuathaigh CMP
    Front Psychiatry; 2021; 12():633476. PubMed ID: 34887781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latent Inhibition in Schizophrenia and Schizotypy.
    Myles L; Garrison J; Cheke L
    Schizophr Bull Open; 2023 Jan; 4(1):sgad026. PubMed ID: 39145328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive schizotypy and the experience of creativity: The distinctive roles of suspiciousness and dispositional mindfulness.
    McDonald H; Babunashvili M; Finn A; Willard A; Valmaggia L; Chadwick P; Antonova E
    Schizophr Res; 2021 Feb; 228():151-158. PubMed ID: 33444933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-referential hypermentalization in schizotypy.
    Wastler HM; Lenzenweger MF
    Personal Disord; 2019 Nov; 10(6):536-544. PubMed ID: 31144838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overshadowing and salience attribution in relation to cannabis use.
    Dawes C; McGreal SJ; Marwaha S; Prados J; Reheis A; Dumitrescu A; Waddington JL; Moran PM; O'Tuathaigh C
    Schizophr Res Cogn; 2024 Sep; 37():100315. PubMed ID: 38764742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The moderating role of early traumatic experiences on the association of schizotypal traits with visual perception.
    Zouraraki C; Kyriklaki A; Economou E; Giakoumaki SG
    Scand J Psychol; 2023 Feb; 64(1):10-20. PubMed ID: 35833570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional support for the cognitive model of schizophrenia: evidence of elevated defeatist beliefs in schizotypy.
    Luther L; Salyers MP; Firmin RL; Marggraf MP; Davis B; Minor KS
    Compr Psychiatry; 2016 Jul; 68():40-7. PubMed ID: 27234181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to elicit a negative bias? Manipulating contrast and saturation with the facial emotion salience task.
    Tholl S; Sojer CA; Schmidt SNL; Mier D
    Front Psychol; 2024; 15():1284595. PubMed ID: 39268387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of positive and negative schizotypy in daily life: an experience sampling study.
    Kwapil TR; Brown LH; Silvia PJ; Myin-Germeys I; Barrantes-Vidal N
    Psychol Med; 2012 Dec; 42(12):2555-66. PubMed ID: 22716971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Multidimensional Schizotypy with PID-5 Domains and Facets.
    Kemp KC; Kaczorowski JA; Burgin CJ; Raulin ML; Lynam DR; Sleep C; Miller JD; Barrantes-Vidal N; Kwapil TR
    J Pers Disord; 2022 Dec; 36(6):680-700. PubMed ID: 36454161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The specificity of referential thinking: a comparison of schizotypy and social anxiety.
    Meyer EC; Lenzenweger MF
    Psychiatry Res; 2009 Jan; 165(1-2):78-87. PubMed ID: 19059651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do patients with schizophrenia exhibit aberrant salience?
    Roiser JP; Stephan KE; den Ouden HE; Barnes TR; Friston KJ; Joyce EM
    Psychol Med; 2009 Feb; 39(2):199-209. PubMed ID: 18588739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizotypy and nicotine, alcohol, and cannabis use in a non-psychiatric sample.
    Esterberg ML; Goulding SM; McClure-Tone EB; Compton MT
    Addict Behav; 2009 Apr; 34(4):374-9. PubMed ID: 19136217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationships among aberrant salience, reward motivation, and reward sensitivity.
    Neumann SR; Linscott RJ
    Int J Methods Psychiatr Res; 2018 Dec; 27(4):e1615. PubMed ID: 29691918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.